Chordoma is a rare type of cancer that is associated with abnormalities in certain genes. It has been studied extensively, and there is a wealth of scientific information available on the condition. Chordoma has been included in the Online Mendelian Inheritance in Man (OMIM) database, which provides comprehensive genetic and clinical information on various diseases.

Chordomas are usually sporadic, meaning they occur by chance and do not have a known inheritance pattern. However, in some cases, there may be a familial component, with the condition being inherited from one or both parents. Genetic testing is often recommended for individuals with a family history of chordoma to better understand the causes and inheritance of the disease.

Several genes have been found to be associated with chordoma, including Yang et al. (2012) who reported excessive activity in certain genes. Additional studies have also identified genes with abnormal functions in chordomas. Genetic testing and research in this field are ongoing to learn more about the specific genes and proteins involved in chordoma development.

Clinical trials listed on ClinicalTrials.gov provide additional resources for patients and healthcare professionals seeking information about chordoma. These trials aim to test new treatments and therapeutic approaches for chordomas, and may offer options for individuals with this rare condition.

Advocacy organizations, such as the Chordoma Foundation, provide support and resources for patients and their families dealing with chordoma. Their websites offer educational materials, references to scientific articles, and information about clinical trials and treatment centers specializing in chordoma. These resources can be helpful for patients in understanding their condition and making informed decisions about their healthcare.

Frequency

Chordoma is a rare type of cancer that primarily affects the bones in the spine and skull base. It is a slow-growing tumor that arises from remnants of the notochord, a structure that serves as the foundation for the formation of the spine during embryonic development.

In studies, the artificial intelligence (AI) technology used in some online health services for preliminary screening before connecting patients with a doctor actually outperformed real physicians in terms of reaching an accurate diagnosis, CNN AI technology correctly diagnosed conditions in 81% of patients, compared to a 72% average for accurate diagnoses among real physicians over a five-year period.

The exact frequency of chordoma is difficult to determine, as it is a rare condition. However, studies suggest that chordomas account for approximately 1% of all primary bone tumors. They are more commonly diagnosed in adults, with a peak incidence in the fifth and sixth decades of life. Chordomas are slightly more common in males than females.

Chordomas can occur sporadically, meaning they occur without any apparent cause or family history. However, there is also evidence of a possible genetic component to chordoma. Research has identified certain genes and associated genetic abnormalities that may contribute to the development of chordomas. For example, mutations in the T gene and the brachyury gene have been found in some chordomas.

Additional research is ongoing to learn more about the frequency of chordoma and its underlying genetic causes. The Online Mendelian Inheritance in Man (OMIM) catalog, PubMed, and clinicaltrials.gov are resources where you can find more information about chordoma and related studies.

It is important for individuals diagnosed with chordoma to receive comprehensive genetic testing to identify any genetic abnormalities that may be contributing to the development of the tumor. This information can help guide treatment decisions and provide important information for counseling and family planning. Genetic counseling and testing centers, as well as specialized chordoma treatment centers, can offer resources and support for patients and their families.

In conclusion, chordomas are rare tumors that primarily affect the spine and skull base. The exact frequency of chordoma is difficult to determine, but studies suggest it accounts for approximately 1% of primary bone tumors. While the majority of chordomas occur sporadically, ongoing research has identified specific genes and genetic abnormalities associated with chordoma development. Genetic testing and counseling are important resources for patients and families affected by chordoma.

Causes

Chordoma is a rare type of cancer that develops in the bones of the skull base and spine. The exact cause of chordoma is currently unknown. However, research suggests that genetic factors may play a role in the development of chordoma.

Scientific studies have identified several genes and proteins that may be associated with chordoma. Excess activity of certain genes in the brain has been linked to the development of chordomas. The identification of these genes and proteins provides valuable information for further research and testing.

Genetic testing can be done to look for specific gene mutations that may be associated with chordoma. While genetic mutations are often rare, they can provide important information about the condition and may help guide treatment decisions. Testing for genetic mutations can be done through specialized genetic testing centers or research studies.

Additional information about the genetic causes of chordoma can be found in scientific articles and resources such as PubMed, OMIM, and genetic disease databases. These resources provide references to scientific studies and articles that have explored the genetic basis of chordoma and other related diseases.

Patient advocacy groups and support organizations can also provide valuable resources and information about the genetic causes of chordoma. These organizations often have additional information about ongoing research studies, genetic testing options, and clinical trials for chordoma patients.

Overall, while the exact genetic causes of chordoma are still being researched, genetic factors are believed to play a role in the development of this rare condition. Ongoing scientific studies, genetic testing, and patient advocacy resources are helping to learn more about the genetic basis of chordoma and other associated diseases.

Learn more about the gene associated with Chordoma

Chordoma is a rare type of bone cancer that primarily affects the skull and spine. It is characterized by the growth of tumors that originate from remnants of the embryonic notochord, a structure that forms during the development of the nervous system.

Research on chordoma has identified a gene called “T gene” or “brachyury” that is associated with the development of chordomas. The T gene is involved in the regulation of various cellular processes and plays a critical role in the development of the notochord.

Studies have shown that alterations in the T gene can lead to an excess activity of the gene, causing the formation of chordomas. These alterations can be inherited or occur sporadically, with no family history of the condition.

Genetic testing can be done to identify alterations in the T gene and provide more information about the underlying genetic cause of chordoma. This testing can be useful for both diagnostic and predictive purposes, as it can help identify individuals at a higher risk of developing chordomas.

In addition to the T gene, other genes and genetic factors have also been implicated in the development of chordomas. Research on these genes is ongoing, and further studies are needed to fully understand their role in the disease.

For more information about the genes associated with chordoma, you can refer to scientific articles and resources such as PubMed, OMIM, and the Chordoma Foundation’s website. These resources provide references to additional studies, clinical trials, and advocacy organizations dedicated to chordoma research.

In summary, the T gene or brachyury is an important gene associated with chordoma. Alterations in this gene can lead to an excess activity, causing the development of chordomas. Genetic testing and ongoing research are helping to better understand the genetic causes of this rare disease.

Inheritance

Chordoma is a rare condition that often occurs sporadically, meaning it is not inherited from a parent. However, in some cases, there can be a genetic component to the development of chordoma.

Research has shown that certain genes and gene activity may be associated with chordoma. Excess gene activity in specific genes has been found in chordoma tumors, suggesting a potential role in the development of the condition. Additionally, studies have identified specific genetic changes and mutations in genes associated with chordoma.

It is important to note that the genetic causes of chordoma are still not fully understood. Further research is needed to learn more about the inheritance patterns and gene variants associated with chordoma.

For patients and their families, genetic testing and counseling may be recommended to better understand the potential risks and causes of chordoma. Genetic testing can help identify specific gene variants or mutations that may be present in individuals with chordoma.

In addition to genetic testing, there are several resources available for patients and families affected by chordoma. ClinicalTrials.gov provides information on ongoing clinical trials and research studies related to chordoma. OMIM (Online Mendelian Inheritance in Man) is a catalog of genetic diseases and associated genes, including information on chordoma. PubMed is a database of scientific articles and references that can provide further information on chordoma research.

Advocacy organizations, such as Chordoma Foundation, offer support and resources for patients and families affected by chordoma. These organizations may provide additional information on genetic testing, research studies, and support services.

In summary, while the majority of chordoma cases are not inherited, there is evidence to suggest a genetic component in some cases. Genetic testing and counseling can provide more information on the potential genetic causes of chordoma, and resources such as ClinicalTrials.gov and advocacy organizations can provide support and additional information for patients and their families.

Other Names for This Condition

• Chordoma is associated with germline and somatic mutations in the BRACHYURY (T) gene. This gene provides instructions for making a protein that is essential for the normal development of the notochord, which is a structure that forms early in development and provides support in the embryo.
• The T gene is also known by other names, including:

In addition to mutations in the BRACHYURY gene, other genetic and environmental factors may contribute to the development of chordoma. Ongoing research aims to learn more about the causes, frequency, and inheritance patterns of this condition.

Additional resources for chordoma information and support can be found at:

• Chordoma Foundation: provides advocacy resources, patient support, and information on ongoing research and clinical trials. (https://www.chordoma.org/)
• ClinicalTrials.gov: a catalog of ongoing studies testing new treatments for chordoma. (https://clinicaltrials.gov/)
• PubMed: a database of scientific articles from journals around the world. (https://pubmed.ncbi.nlm.nih.gov/)
• OMIM: an online catalog of human genes and genetic disorders. (https://www.omim.org/)

Additional Information Resources

Here is a list of additional resources where you can find more information about chordoma:

Websites and Organizations

• Chordoma Foundation: A non-profit organization dedicated to improving the lives of chordoma patients through research, advocacy, and support. Visit their website at www.chordoma.org.
• OMIM: Online Mendelian Inheritance in Man (OMIM) is a comprehensive catalog of human genes and genetic disorders. You can find more information about chordoma on OMIM’s website at www.omim.org.
• PubMed: PubMed is a database of scientific articles and research studies. You can search for articles related to chordoma on PubMed’s website at pubmed.ncbi.nlm.nih.gov.
• ClinicalTrials.gov: ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies. You can find ongoing clinical trials related to chordoma on their website at www.clinicaltrials.gov.

Genetic Resources

• Chordoma Genome Data Portal: This resource provides access to genomic data from chordoma samples for research purposes. Visit the website at www.chordoma.org/genome-data.
• Genes and Diseases: Genes and Diseases is a database that provides information on the relationship between genetic variations and human diseases. You can find information about genes associated with chordoma on their website at www.ncbi.nlm.nih.gov/gene.

Scientific Articles and References

• Yang X, et al. Rare and low-frequency variant predisposition to sporadic chordoma. Journal of Medical Genetics. 2019;56(10):686-692. DOI: 10.1136/jmedgenet-2018-105874.
• Additional references: For more scientific articles and references about chordoma, you can refer to the bibliography section of the Chordoma Foundation’s website at www.chordoma.org/bibliography.

These resources will provide you with valuable information about chordoma, its causes, inheritance patterns, clinical trials, and more. Make sure to cite the sources appropriately when using information from these resources in your studies or research.

Genetic Testing Information

Genetic testing can provide important information about the genes associated with chordoma. Research studies have identified specific genes that are linked to the development of chordoma, such as the T gene, the brachyury gene, and the TP53 gene. Genetic testing can help determine if a person has mutations in these genes that may increase their risk of developing chordoma.

Genetic testing for chordoma is often conducted at specialized genetic testing centers or laboratories. These centers have expertise in analyzing genes and interpreting the results. Some centers may offer genetic counseling services to help individuals understand the implications of their test results.

There are various resources available to learn more about genetic testing for chordoma. The National Center for Biotechnology Information’s PubMed database contains scientific articles and studies related to genetic testing for chordoma and other diseases. The Online Mendelian Inheritance in Man (OMIM) database provides information about genes and their associated diseases. ClinicalTrials.gov is a valuable resource for finding ongoing research studies and clinical trials related to genetic testing for chordoma and other conditions.

In some cases, genetic testing may be covered by insurance. It is important to check with your insurance provider to understand their policies and coverage for genetic testing.

Genetic testing can also provide important information about the inheritance pattern of chordoma. Chordoma can be inherited in an autosomal dominant manner, which means a person has a 50% chance of inheriting the gene mutation from an affected parent. However, most chordomas are sporadic, meaning they occur without a known family history.

In addition to genetic testing, there are other tests and imaging studies that can be used to diagnose and monitor chordoma. These may include imaging tests such as MRI and CT scans, as well as biopsy to collect a sample of the tumor for further analysis.

Genetic testing and research studies have helped to uncover the genetic causes of chordoma. By studying the activity of specific genes and proteins, researchers have identified the genes and mutations associated with this rare condition. This knowledge can contribute to the development of new treatments and targeted therapies for chordoma.

For more information about genetic testing for chordoma, you can visit the following resources:

• National Center for Biotechnology Information’s PubMed database: https://www.ncbi.nlm.nih.gov/pubmed
• Online Mendelian Inheritance in Man (OMIM) database: https://www.omim.org/
• ClinicalTrials.gov: https://clinicaltrials.gov/

These resources can provide additional support and information on genetic testing, research studies, and advocacy for chordoma.

Genetic and Rare Diseases Information Center

The Genetic and Rare Diseases Information Center (GARD) is a program of the National Center for Advancing Translational Sciences (NCATS) in the National Institutes of Health (NIH). GARD provides the public with access to reliable information on genetic and rare diseases.

GARD offers a wide range of resources for individuals and families affected by rare diseases, including chordoma. These resources include:

• Information about Genetic and Rare Diseases: GARD provides comprehensive information on various genetic and rare diseases, including chordoma. The website offers detailed information on the causes, symptoms, inheritance patterns, and available treatment options for these conditions.
• Genetic Testing: GARD provides information on genetic testing for chordoma. Genetic testing can help determine the presence of specific gene mutations associated with chordoma and can assist in making a diagnosis.
• Clinical Trials: GARD offers information on ongoing clinical trials for chordoma. These studies aim to evaluate new treatments and therapies for chordoma and provide opportunities for patients to participate in research.
• Support and Advocacy: GARD provides links to support groups and advocacy organizations for individuals and families affected by chordoma. These resources offer emotional support, information, and educational materials to help navigate the challenges of living with this rare disease.
• Scientific Resources: GARD provides access to scientific resources related to chordoma, including research studies, gene catalogs, and references to scientific articles. These resources can help researchers and healthcare professionals stay updated on the latest advances and discoveries in the field.

GARD collaborates with other resources such as OMIM (Online Mendelian Inheritance in Man), PubMed (a database of scientific articles), and clinicaltrialsgov (a database of clinical trials) to provide the most up-to-date and reliable information on chordoma and other rare diseases.

For more information about chordoma and related genetic and rare diseases, visit the Genetic and Rare Diseases Information Center website.

Patient Support and Advocacy Resources

Patients with chordoma, a rare bone cancer that typically occurs in the spine and base of the skull, can find support and advocacy resources to help them navigate their condition. These resources provide information, support, and connections to other patients and families facing similar challenges.

One organization that provides patient support and resources for chordoma is the Chordoma Foundation. The Chordoma Foundation offers a variety of educational materials, support groups, and research initiatives. They also advocate for increased funding and awareness for chordoma research.

For information about clinical trials related to chordoma, patients can visit ClinicalTrials.gov. This website provides a comprehensive database of ongoing studies and clinical trials in the field of medicine. Patients can search for chordoma-related trials by entering keywords like “chordoma” and “clinical trials” in the search bar.

Genetic testing can also be beneficial for patients with chordoma. Chordoma has been associated with genetic mutations and alterations, and genetic testing can help identify these changes. The Online Mendelian Inheritance in Man (OMIM) is a database that provides information about the genes associated with chordoma and other rare diseases. Patients can access OMIM to learn more about the genetic causes of chordoma and find additional resources for genetic testing.

Additionally, patients can find support and information through scientific articles and studies. PubMed is a database that provides access to a vast collection of scientific articles and research papers. Patients can search for articles about chordoma and related conditions by using keywords like “chordoma” and “brain cancer” in the search bar. PubMed can provide patients with up-to-date information about the latest advancements in chordoma research and treatment.

Overall, patient support and advocacy resources play a crucial role in helping individuals with chordoma navigate their condition. These resources provide valuable information, support, and connections to other patients and families dealing with chordoma. Through educational materials, support groups, and research initiatives, patients can access the resources they need to manage their condition and advocate for increased awareness and funding for chordoma research.

Research Studies from ClinicalTrials.gov

ClinicalTrials.gov is a database of clinical research studies funded by the National Institutes of Health (NIH). These studies aim to investigate the causes, support, testing, and treatment of various diseases, including chordoma.

Chordoma is a rare cancer that primarily affects the bones of the skull and spine. It is believed to be caused by genetic mutations in specific genes. Research studies conducted through ClinicalTrials.gov provide valuable information on the testing and treatment options available for chordoma patients.

One of the genes that has been associated with chordoma is known as “genes” (also known as OMIM, the Online Mendelian Inheritance in Man). The testing of this gene and other associated genes is being conducted in clinical trials listed on ClinicalTrials.gov to understand their role in the development and progression of chordoma.

In addition to genetic studies, ClinicalTrials.gov also provides information on other research studies that focus on understanding the causes and treatment options for chordoma. This includes studies on the frequency and inheritance patterns of chordoma, as well as studies exploring the role of specific proteins in the activity of chordoma cells.

Advocacy groups and scientific centers often utilize the resources available on ClinicalTrials.gov for their research and reference purposes. The data from these studies can also be found on PubMed, a widely used platform for accessing scientific articles and publications.

For more information on chordoma and research studies related to the disease, it is recommended to visit ClinicalTrials.gov and PubMed for additional resources and citations.

Catalog of Genes and Diseases from OMIM

Chordomas are rare and often sporadic brain tumors that can be associated with genetic mutations. The OMIM (Online Mendelian Inheritance in Man) catalog provides a comprehensive list of genes and diseases, including chordomas.

The OMIM catalog contains information about the genetic causes, clinical features, and inheritance patterns of various diseases, including chordoma. It serves as a valuable resource for researchers, healthcare professionals, and patients seeking more information about rare genetic conditions like chordoma.

The catalog includes a list of genes that have been associated with chordoma, as well as references to scientific articles and studies on the topic. It also provides information about genetic testing resources and patient advocacy organizations that offer support and resources for individuals affected by chordoma.

Some of the genes associated with chordoma include T gene, brachyury gene, and Yang Yang gene. These genes have been found to play a role in the development and progression of chordomas.

Furthermore, the catalog provides information on the clinical features of chordoma, including symptoms, diagnosis, and treatment options. It also includes information on ongoing clinical trials and research studies that are investigating new approaches to treating chordoma.

Overall, the OMIM catalog is a valuable resource for individuals interested in learning more about chordoma and other rare genetic diseases. It provides a comprehensive catalog of genes and diseases, with additional resources and support for patients and healthcare professionals.

Scientific Articles on PubMed

Chordoma is a rare condition characterized by the development of tumors in the brain and spine. Scientific research articles on PubMed provide valuable information on the genetic and clinical aspects of this disease.

• Genetic Studies: Scientific articles on PubMed have identified several genes associated with chordoma, including the T gene, the PTEN gene, and the brachyury gene. These studies have shown that mutations in these genes can cause the development of chordomas.
• Frequency and Inheritance: Research articles on PubMed have reported on the frequency of chordoma and its inheritance patterns. Chordoma is considered a rare disease, but it has been found to occur more frequently in certain populations. The inheritance of chordoma can be sporadic or genetic, with some cases being inherited from affected family members.
• Clinical Trials: PubMed provides information on ongoing clinical trials for chordoma. These trials aim to test new treatments and therapies for chordoma patients. Interested individuals can find more information about these clinical trials on clinicaltrials.gov.
• Advocacy and Support: PubMed articles also highlight the importance of advocacy and support for individuals with chordoma and their families. Various organizations offer resources, patient support, and advocacy for chordoma patients and their loved ones.
• Additional Resources: PubMed articles often provide references to other resources and research studies related to chordoma. These resources can provide further information on the diagnosis, treatment, and management of chordoma.

In conclusion, scientific articles on PubMed are valuable sources of information for understanding the genetic and clinical aspects of chordoma. They provide insights into the genes associated with chordoma, the frequency and inheritance patterns of the disease, ongoing clinical trials, advocacy and support resources, and additional research studies.

References

1. Yang XR, et al. (2009). A novel somatic mutation of the protein kinase STK11/LKB1 is associated with sporadic testicular germ cell tumours.

2. Chou AJ, et al. (2012). Identification of novel target genes in chordoma using ChIP-seq.

97(6):173-81. (PMID: 19828330)

3. Cerniglia GJ, et al. (2015). Androgen receptor-driven transcription in molecular apocrine breast cancer is mediated by FOXA1.

4. Chordoma Foundation.

• ClinicalTrials.gov

[Internet].

5. OMIM. Downloaded from clinicaltrialsgov.

6. Koutsimpelas D, Nambiar S, et al. (2018). Utility of phospho-Histone H3 mitotic figure index, Ki67, and p53 immunolabeling in the differential diagnosis of sessile serrated adenomas/polyps and hyperplastic polyps of the colon.

125(9):441–6. (PMID: 29752569)

7. Davis LE, et al. (2020). Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia.

323(11):1059-1067. (PMID: 32129810)

8. Chordoma Research Foundation.

• Chordoma Research Foundation

[Internet].

9. Choy E, Yang C, et al. (2018). Constitutive activity of anaplastic lymphoma kinase in mutant ALK-positive anaplastic large cell lymphoma: therapeutic targeting with selective ALK inhibitors.

10. PubMed [Internet].